EKF Diagnostics Holdings plc (LON:EKF – Get Free Report)’s share price shot up 10.8% on Saturday . The stock traded as high as GBX 26.60 ($0.33) and last traded at GBX 26.60 ($0.33). 1,224,627 shares were traded during mid-day trading, an increase of 205% from the average session volume of 401,221 shares. The stock had previously closed at GBX 24 ($0.30).
EKF Diagnostics Stock Up 10.8 %
The firm has a 50-day moving average of GBX 26.38 and a two-hundred day moving average of GBX 27.87. The company has a quick ratio of 1.77, a current ratio of 4.59 and a debt-to-equity ratio of 1.78. The company has a market capitalization of £120.69 million, a PE ratio of 2,660.00 and a beta of 0.57.
About EKF Diagnostics
EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T analyzer; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples.
Read More
- Five stocks we like better than EKF Diagnostics
- How is Compound Interest Calculated?
- XPO Stock Gains Momentum as U.S. Trade Outlook Evolves
- Insider Trades May Not Tell You What You Think
- CarMax Gets in Gear: Is Now the Time to Buy?
- What does consumer price index measure?
- Qubit Combat: 2 Stocks Battle for Quantum Supremacy
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
